Clinical features of familial clustering in patients infected with 2019 novel coronavirus in Wuhan, China-Reference-Cited by-同舟云学术

Clinical features of familial clustering in patients infected with 2019 novel coronavirus in Wuhan, China

Published:2020-09 Issue: Volume:286 Page:198043
ISSN:0168-1702
Container-title:Virus Research
language:en
Short-container-title:Virus Research

Author:

Li Jinzhong,Gong Xiaobing,Wang Zhigang,Chen Renzhou,Li Taoyuan,Zeng Dongyu,Li Minran

Publisher

Elsevier BV

Subject

Cancer Research,Infectious Diseases,Virology

Reference21 articles.

1. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster;Chan;Lancet,2020

2. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster;Chan;Lancet (London, England),2020

3. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy;Chen;Lancet,2020

4. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study;Chen;Lancet (London, England),2020

5. Notice on Issuing a New Coronavirus Pneumonia Prevention and Control Plan;General Office of the National Health and Health Commission,2020

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impactos da vacinação na morbimortalidade por COVID-19 entre pessoas idosas;Rev Rene;2024-08-21

2. Contamination of High-Touch Surfaces in the Ophthalmic Clinical Environment—A Pilot Study;Hygiene;2024-07-22

3. SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local Immunity;Vaccines;2024-07-18

4. Is Coagulation-related indicators associated with COVID19-related mortality? A evidence obtained from 663 Chinese patients with COVID-19 infection in a retrospective cohort study;2024-06-12

5. The extracellular cyclophilin A-integrin β2 complex as a therapeutic target of viral pneumonia;Molecular Therapy;2024-05